Back

EB Medicine

  • Antifibrinolytic Agents
  • Brain Injuries, Traumatic
  • Hemorrhage
  • Hyphema
  • Tranexamic Acid

Tranexamic Acid for Management of Acute Hemorrhage in Pediatric Patients in the Emergency Department

Tranexamic acid (TXA) is an antifibrinolytic medication with multiple routes of topical and systemic administration that can be used to treat acute hemorrhage across a broad range of clinical scenarios. Pediatric data are more limited than the adult literature, which benefits from larger, higher-quality studies; however, TXA remains a potentially effective, safe, and versatile option for temporizing bleeding and limiting blood loss in children. This review discusses the evidence on TXA use in traumatic hemorrhage, traumatic brain injury, posttonsillectomy bleeding, epistaxis, oral and gingival bleeding, lower airway bleeding, and traumatic hyphema.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 4 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Paid · fee on provider site

See fees on ebmedicine.net

Listed by the provider

  • Journal-based
  • Credit · Up to 4 credits
  • Paid · fee on provider site
  • Released
    Jul 1, 2026
  • Last day to claim credit
    Jul 2, 2029 3 years left